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Abstract
Purpose Intermediate uveitis (IU) is generally believed to
be autoimmune in nature requiring systemic corticosteroid
and immunomodulatory therapy. This belief stems from the
published reports from the developed countries; and the
scenario maybe different in the developing countries that
maybe endemic for certain infections. There are no large
series available on the etiologic causes of intermediate
uveitis from the developing countries. The present series
aims to describe the etiology, treatment, and course of IU in
North Indian population.
Methods In a retrospective analysis, records of 205 patients
seen with a referral diagnosis of IU were retrieved and
analyzed. After determining the etiology, 122 patients who
had a definitive diagnosis of IU and a minimum follow-up
of 1 year were analyzed further. All patients underwent
investigations to rule out any possible etiology and received
stepwise therapy comprising of depot or systemic cortico-
steroids, immunosuppressive/immunomodulatory therapy
and pars plana vitrectomy. Specific therapy was adminis-
tered wherever etiology could be determined. The primary
outcome measure was recurrence of inflammation after a
minimum of 6 months of initiating treatment.
Results There were 55 men and 67 women, and the disease
was bilateral in 82 patients. Tuberculosis was the most
common underlying etiology seen in 57 (46.7%), followed
by sarcoidosis in 22 (18%), pars planitis in 35 (28.7%), and
IU of idiopathic type in 8 (6.5%). Seventy three (59.8%) of
122 patients received systemic steroids, 55 (45.1%) were
treated with periocular steroid, and 19 (15.6%) received
immunomodulatory therapy. Specific antimicrobial therapy
in the form of antitubercular treatment (ATT) was given in
42 patients. The recurrences were seen in 35 patients
(28.7%) over a median follow-up of 18 months. Recur-
rences were seen more commonly in eyes with snow
banking (P=0.011); cystoid macular edema (P=0.015), and
in eyes that received local therapy (P=0.001). Out of 57
patients who were diagnosed as intraocular tuberculosis, 42
patients (73.6%) received specific antitubercular treatment.
Only 5 of 42 patients (11.9%) who received ATT had
recurrence of inflammation compared to 7 out of 15
patients (46.7%) who did not receive ATT (P=0.005).
Conclusions Tuberculosis is an important etiologic cause of IU
in developing countries like India where the disease is endemic.
It is important to investigate these patients as specific therapy
with ATT helped in reducing the recurrences significantly.
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Intermediate uveitis (IU) was defined by International
Uveitis Study Group (IUSG) as idiopathic inflammatory
syndrome, mainly involving the anterior vitreous, periph-
eral retina, and ciliary body with minimal or no anterior
segment inflammation [1]. The term intermediate uveitis
was used synonymously with pars planitis by IUSG and
thus most of the intermediate uveitis was assumed to be
idiopathic in etiology. The Standardization of Uveitis
Nomenclature (SUN) Working Group defined IU as that
subset of uveitis where vitreous is the major site of
inflammation and the presence of peripheral vascular
sheathing and macular edema should not change the
classification [2]. The same group defined “pars planitis”
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as subset of IU where there is snowball or snow bank
formation occurring in the absence of any systemic disease,
i.e., idiopathic. [2] The etiology of IU is not well known
and is mostly believed to be autoimmune, although it may
be associated with systemic illness such as sarcoidosis,
multiple sclerosis (MS) and several infectious diseases [3–
6]. The disease is known for its prolonged course with
exacerbations and hence the need for investigations to
search for a specific etiology and proper management to
reduce the recurrence and complications. The etiology may
be variable in different parts of the world as it could be
influenced by the geographic variations and ethnicity. The
studies available from the developed countries [3–5] and
one from North Africa [7] have mostly indicated IU to be of
autoimmune in nature. In the cross-sectional epidemiologic
studies done from the referral institutes in India, interme-
diate uveitis has been reported to be idiopathic in 77.5% in
Northeast India [8], 91.4% in North India [9], and 81.6% in
South India [10]. However, none of these studies describe
the longitudinal course, management, and outcome of these
patients labeled as intermediate uveitis. The present study
was undertaken to find the etiologic spectrum, clinical
manifestations, course, complications, and visual outcome
in patients with IU from a single center in North India.
Material and methods
We analyzed 15-year data (January 1995 through June
2009) from medical records of uveitis clinic of Post
Graduate Institute of Medical Education and Research,
Chandigarh, India. The medical record of all patients with
diagnosis of IU as per the SUN working group criteria was
analyzed in detail. Only patients with a minimum of 1-year
follow-up were included. All the patients who did not
complete a minimum 1 year of follow-up or where the
disease showed significant granulomatous anterior segment
inflammation during follow-up were excluded from further
analysis. Patients of Fuchs uveitis and Behcet's disease who
were initially misdiagnosed as IU were also excluded from
further analysis.
All the enrolled patients had their records of history and
ocular and systemic examination available at presentation
as well as during follow-up visits. All patients had a
detailed history recorded in the uveitis clinic file and
underwent a complete ophthalmic examination including
best corrected visual acuity, intraocular pressure, slit lamp
biomicroscopy, and posterior segment examination with
both slit lamp biomicroscopy and indirect ophthalmoscopy
to examine pars plana area. Ancillary tests including fundus
fluorescein angiography, optical coherence tomography, or
ultrasound biomicroscopy, and specific laboratory tests
were done as and when indicated. Systemic evaluation
was done by a senior consultant internist who has special
interest in systemic inflammatory diseases. Patients under-
went baseline investigations including complete blood
counts, erythrocyte sedimentation rate, tuberculin skin test,
chest radiography, and Treponema pallidum hemagglutina-
tion test. Other targeted laboratory tests like serum
angiotensin-converting enzyme level, Borrelia serology,
chest computed tomography, magnetic resonance imaging
(MRI) scan of the brain, and human leukocyte antigen
typing were done whenever required. The following
algorithm was followed: firstly, all the patients of Fuchs
uveitis where vitritis was significant and mislead to the
diagnosis of IU were excluded. Secondly, the patients with
typical pars planitis as well as those with IU with/without
snow banks and posterior synechia were investigated for
infectious etiologies like tuberculosis (TB), sarcoidosis,
Lyme and systemic associations like MS were ruled out. In
patients with preponderant vitritis, etiologies like toxocar-
iasis, lymphoma, candida, and Whipple's disease were ruled
out. In patients with prepondrant vasculitis, MRI was done
to rule out multiple sclerosis and intracranial lymphomas.
Patients were diagnosed as intermediate uveitis of
presumed tubercular etiology if the following criteria were
fulfilled: (1) a documented positive tuberculin skin test
(10 mm of induration or more) at 48–72 h; (2) evidence of
vitritis, snowballs, or snow banking; and (3) all known
causes of infectious uveitis except TB and known nonin-
fectious uveitic syndromes ruled out. Pars planitis was
defined as subset of intermediate uveitis associated with
snow bank or snowballs formation in the absence of an
associated infection or systemic disease. When typical
features of pars planitis are not present and the etiology
could not be determined, then the term “intermediate uveitis
of idiopathic type” was used.
The patients received treatment if (1) the visual acuity
was worse than 20/40, (2) presence of cystoid macular
edema, (3) vitreous haze of 2+ or more, and (4) retinal
neovascularization. A stepwise graded approach to treat-
ment included periocular steroid injection, systemic cortico-
steroids, immunosuppressive/immunomodular therapy, and
pars plana vitrectomy. In cases with unilateral or asymmet-
ric involvement, the periocular steroid injections were given
first, and systemic treatment was initiated only in cases with
insufficient effect and/or intolerance to this treatment
modality. Systemic steroids (1–1.5 mg/kg body weight)
were started in cases with severe bilateral disease and/or in
cases with decrease visual acuity due to vitreous opacities.
Immunosuppressive agents were started as a steroid-sparing
drug or when steroid failed to control the inflammation. IU
patients with presumed TB in addition also received
antitubercular therapy (ATT). Pars plana vitrectomy was
done if the vitritis was very severe at the time of
presentation to our center despite receiving initial therapy
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outside and the laboratory investigations were equivocal
and to manage the complications like retinal detachment
and vitreous hemorrhage.
The primary outcome measure was the recurrence of
inflammation occurring after a minimum of 6 months of
receiving treatment. Visual improvement was defined as
halving of the visual angle and visual deterioration as
doubling of the visual angle. Visual acuity was said to be
stabilized if the final visual acuity remained within two
lines of the presenting acuity.
The statistical analysis was carried out using Statistical
Package for Social Sciences (SPSS Inc., Chicago, IL,
version 15.0 for Windows Evaluation Version). All quan-
titative variables were estimated using measures of central
location (mean, median) and measures of dispersion
(standard deviation). Normality of data was checked by
measures of Kolmogorov–Smirnov tests of normality. For
normally distributed data, means for more than two groups
were compared using Kruskal–Wallis test. Qualitative or
categorical variables were described as frequencies and
proportions. Proportions were compared using chi-square
test. All statistical tests were two sided and performed at a
significance level of α=0.05.
Results
Our study included 205 patients with a diagnosis of IU seen
between years 1996 and 2009. Of these 205 patients, 122
fulfilled the inclusion criteria with at least 1 year of follow-
up and were analyzed further. There were 55 men (45.1%)
and 67 women (54.9%) with male-to-female sex ratio of
1:1.2. The mean age at diagnosis was 36.1±13.3 years
(range 5–68 years). The disease was bilateral in 82 patients
(67.2%). Presenting complaints were decreased vision in
100 patients (81.9%), redness in 52 patients (42.6%), pain
in 42 patients (34.4%), and floaters in 40 patients (32.7%).
The most common sign at presentation was vitritis seen in
all 204 eyes (100%) and snowballs in 177 eyes (86.8%).
Snow banking was present in 40 eyes (19.6%). Associated
anterior segment inflammation was seen in 128 eyes
(62.7%).
Of these 122 patients, 57 (46.7%) had underlying
etiology of presumed TB and 22 patients (18%) had
sarcoidosis. Thirty-five patients (28.7%) were diagnosed
as pars planitis while 8 patients (6.5%) were diagnosed as
IU of idiopathic type (Table 1). The clinical features at
presentation were comparable in all the groups irrespective
of etiology (Table 2).
Seventy three (59.8%) of 122 patients received systemic
steroids, 55 patients (45.1%) were treated with periocular
steroid. Nineteen patients (15.6%) received immunomodu-
latory therapy. Twelve patients (9.8%) with good visual
acuity and minimal inflammation received only topical
steroids. Specific antimicrobial therapy in the form of ATT
was given in 42 patients.
The most common complications seen over the follow-
up were the development of cystoid macular edema (CME)
in 92 eyes (45.1%), cataract in 70 eyes (34.3%), glaucoma/
ocular hypertension in 23 eyes (11.2%), and epiretinal
Table 2 Clinical signs at presentation











AC reaction 12 (85.7%) 61 (64.2%) 28 (50%) 27 (69.2%) 128 (62.7%) 0.165
Vitreous cells 14 (100%) 95 (100%) 56 (100%) 39 (100%) 204 (100%)
Snowballs 10 (71.4%) 82 (86.3%) 49 (87.5%) 36 (92.3%) 177 (86.8%) 0.266
Snow banking 6 (42.9%) 16 (16.8%) 14 (25%) 4 (10.3%) 40 (19.6%) 0.037
AC anterior chamber, IOTB intraocular tuberculosis
Table 1 Demographic profiles of patients










Age 41±12.8 37.5±12.1 28.3±13.4 42.2±12.2 36.1±13.3
Sex (M/F) 1:1.6 1:1.1 1.3:1 1:2.6 1:1.2
Bilateral 7 (87.5%) 37 (64.9%) 21 (60%) 17 (77.3%) 82 (67.2%)
M male, F female, IU intermediate uveitis
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membrane (ERM) in 29 eyes (14.2%). Other complications
noted were optic disc pallor in nine eyes (4.4%), peripheral
neovascularization in eight eyes (3.9%), retinoschisis in
four eyes (1.9%), retinal detachment in two eyes (0.9%)
and vitreous hemorrhage in one eye (0.5%) (Table 3). Of
the eight patients developing retinal neovascularization, six
had presumed intraocular tuberculosis (IOTB) as an
underlying etiology. Thirty-five eyes (17.1%) underwent
surgery for the complication of intermediate uveitis
including cataract surgery with posterior intraocular lens
implantation in 28 eyes (13.7%), three-port pars plana
vitrectomy in 5 eyes (2.4%), and glaucoma filtering surgery
in 2 eyes (0.9%). Nine patients underwent laser photoco-
agulation for peripheral neovascularization (six patients;
8 eyes), retinal breaks (two patients; 2 eyes), and for
macroanuerysm (one patient; 1 eye).
The recurrences were seen 35 patients (50 eyes) over
follow-up ranging between 1 and 10 years (mean, 31.9±
30.21 months/median, 18 months) (Fig. 1). Recurrences
were seen more commonly in eyes with snow banking with
16 of 40 eyes (40%) with snow banking having recurrence
compared to 34 of 164 eyes (20.7%) without snow banking
(P=0.011). Recurrences were significantly higher in
patients having cystoid macular edema with 30 of 92 eyes
(32.6%) with CME having recurrence compared to 20 of
112 eyes without CME (17.9%) (P=0.015). Patients
receiving local therapy had higher recurrences compared
to those receiving systemic therapy with 32 of 86 eyes
(37.2%) receiving local therapy in the form of posterior sub
-tenon triamcinolone had recurrence as compared to 18 of
118 eyes (15.2%) who did not received local therapy (P=
0.001). Out of 57 patients who were diagnosed as
intraocular tuberculosis, 42 patients (73.6%) received
specific antitubercular treatment. Eleven patients (19.2%)
received only oral steroids without ATT and 4 patients
received only topical steroids. Five of 42 patients (11.9%)
who received ATT had recurrence of inflammation as
compared to 7 out of 15 patients (46.7%) who did not
receive ATT. The effect of antitubercular therapy in
reducing the number of recurrences of IU in patients
receiving ATT was found to be statistically significant
(P=0.005) (Figs. 1 and 2).
Fig. 2 Comparison of recurrences within IU with presumed TB
group. ATT antitubercular treatment
Fig. 1 Recurrences in different etiologies. IU intermediate uveitis,
IOTB intraocular tuberculosis
Table 3 Complications associated with IU










CME 9 (64.3%) 38 (40%) 25 (44.6%) 20 (51.3%) 92 (45.1%)
Cataract 8 (57.1%) 37 (38.9%) 7 (12.5%) 18 (46.2%) 70 (34.3%)
Glaucoma/ocular hypertension 1 (7.1%) 6 (6.3%) 11 (19.6%) 5 (12.8%) 23 (11.2%)
ERM 7 (50%) 9 (9.5%) 5 (8.9%) 8 (20.5%) 29 (14.2%)
Optic disc pallor 0 5 (5.3%) 2 (3.6%) 2 (5.1%) 9 (4.4%)
Peripheral neovascularization 0 5 (5.3%) 1 (1.8%) 2 (5.1%) 8 (3.9%)
Retinoschisis 0 2 (2.1%) 1 (1.7%) 1 (2.5%) 4 (1.9%)
Retinal detachment 0 1 (1.05%) 0 1 (2.5%) 2 (0.9%)
Vitreous hemorrhage 0 1 (1.05%) 0 0 1 (0.5%)
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The mean visual acuity at presentation was 20/50 (range
20/20—counting fingers at 2 ft) and final visual acuity was
20/30 (range 20/20–20/400). After treatment, visual acuity
improved in 107 eyes (52.4%), deteriorated in 16 eyes
(7.8%), and stabilized in 81 eyes (39.7%). A final visual
acuity of 20/40 or more could be achieved in 85 patients
(69.6%). Factors associated with poor visual outcome were
cataract (P=0.0001), CME (P=0.0001) and ERM (P=
0.01). There was no difference in the final visual outcome
between different subgroups.
Discussion
The overall age of presentation, gender distribution, and
laterality were comparable to previously reported series
[3–5, 11–13]. Vitritis was the most common finding seen
in our series seen in all the patients and snow banking was
seen in 20% of eyes; a finding that is in accordance with
the previously reported series. However, the number of
eyes showing snowballs at presentation was significantly
higher in our series compared to previously published
series [7]. This could be due to the presence of TB as an
etiology cause in 46.7% of our patients as the eyes with
TB had higher incidence of snowballs seen at the time of
presentation compared to those with non-tubercular
etiologies.
In the present series including patients from India, a
country endemic for tuberculosis, nearly 46.7% cases with
IU had TB as an etiology. This is a significant finding as
none of the previous series from other parts of the world
have reported TB as an important underlying cause of IU
[3–6]. On the contrary, the study from Northeast India did
report TB and sarcoidosis as important etiologies in IU [8].
In our previous report, we had analyzed the uveitis patients
seen between years 1996 and 2001 and reported TB and
sarcoidosis seen in 4% each in cases with IU [9]. However,
the different set of criteria was used for making a diagnosis
of tubercular uveitis [9]. In the previously published data
[9], patient was diagnosed as presumed IOTB if he/she
fulfilled any two of the three criteria including (a) clinical
suspicion of the disease where any two of the following
features were present: (1) granulomatous anterior uveitis,
(2) active periphlebitis, (3) neuroretinitis, (4) retinochor-
oiditis, and. (5) subretinal abscess/granuloma; (b) corrobo-
rative evidence of disease: (1) Mantoux >20 mm/necrosis,
(2) positive chest X-ray, (3) aqueous or vitreous tap positive
for Mycobacterium tuberculosis (PCR), (4) sputum positive
for acid-fast bacilli on smear, culture, or both, and (5)
histopathological evidence of tuberculosis from cervical or
parahilar lymph nodes; and (c) response to ATT. Since the
presence of vitritis alone did not qualify the clinical criteria
for presumed IOTB, many of these patients were not
diagnosed as TB. In the current study, the inclusion criteria
were less stringent and modified to include the evidence of
vitritis, snowballs, or snow banking as clinical features with
a documented positive tuberculin skin test (10 mm of
induration or more).
It is important to emphasize this issue because many
ophthalmologists may not routinely investigate these
patients for TB which can lead to prolonged disease
course with multiple recurrences for want of receiving
specific antituberculosis therapy. The administration of
ATT led to significant reduction in the number of
recurrences during follow-up in the present series, thus
highlighting the benefit of adding timely ATT in these
patients. There were no clinical indicators predictive of
possible tubercular etiology at presentation but during
follow-up, the eyes with presumed tubercular IU had
more tendency to develop retinal neovascularization.
Thus, it is important to keep these eyes under close
monitoring for the development of areas of capillary
nonperfusion and retinal neovascularization.
The visual prognosis was good in present series as about
70% patients could achieve a final visual acuity of 20/40 or
better. Presence of cystoid macular edema, cataract, and
epiretinal membranes were associated with poor visual
outcome. Since all these factors indicate an irreversible
cause of visual loss, many of these are likely to improve
further after the surgical management, thus improving the
prognosis even further.
In summary, the results of present series indicate that in
Indian population, IU is more likely to be due to TB than
multiple sclerosis or any other etiology. Timely manage-
ment of these patients leads to improvement/stabilization of
vision in 93% of the eye with 70% achieving a final visual
acuity of 20/40 or better.
Open Access This article is distributed under the terms of the
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